Assessing smoking cessation services and pharmacotherapy in Namibia: findings and implications for future policy initiatives

References

• World Health Organization. WHO global report on trends in prevalence of tobacco use 2000–2025. 3rd ed. Geneva: WHO; 2019 [cited 2021 July 2]. Available from: https://www.who.int/publications/i/item/who-global-report-on-trends-in-prevalence-of-tobacco-use-2000-2025-third-edition
   Google Scholar
• WHO. WHO global report on trends in prevalence of tobacco smoking - 2015. 2015 [cited 2021 June 30]. Available from: http://apps.who.int/iris/bitstream/10665/156262/1/9789241564922_eng.pdf?ua=1
   Google Scholar
• Blecher E, Ross H. Tobacco use in Africa: tobacco control through prevention. American Cancer Society; 2013 [cited 2021 June 30]. Available from: https://www.researchgate.net/publication/276418525
   Google Scholar
• Nashilongo MM, Singu B, Kalemeera F, et al. Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovasc Drugs Ther. 2017;31(5–6):565–578.
   PubMed Web of Science ®Google Scholar
• WHO. Noncommunicable diseases fact sheet. 2018 [cited 2021 July 2]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/noncommunicable-diseases
   Google Scholar
• Ministry of Health and Social Services - Primary Health Care Directorate, Family Health Division. Non-Communicable Diseases (NCDs) programme November 2017. [cited 2021 June 30]. Available from: https://www.iccp-portal.org/system/files/plans/NAMIBIA%20NATIONAL%20MULTISECTORAL%20STRATEGIC%20PLAN%20FOR%20PREVENTION%20AND%20CONTROL%20OF%20NCDs.pdf
   Google Scholar
• Hamid S, Groot W, and Pavlova M. Trends in cardiovascular diseases and associated risks in sub-Saharan Africa: a review of the evidence for Ghana, Nigeria, South Africa, Sudan and Tanzania. Aging Male. 2019:22(3):169-76.
   PubMed Web of Science ®Google Scholar
• Schultz WM, Kelli HM, Lisko JC, et al. Socioeconomic status and cardiovascular outcomes: challenges and interventions. Circulation. 2018;137(20):2166–2178.
   PubMed Web of Science ®Google Scholar
• Jones CA, Perera A, Chow M, et al. Cardiovascular disease risk among the poor and homeless - what we know so far. Curr Cardiol Rev. 2009;5(1):69–77.
   PubMedGoogle Scholar
• Mwita J, and Godman B. Poverty and cardiovascular diseases in sub-Saharan Africa. In: Monyeki KD, Kemper HCG, editors. Chapter in lifestyle and epidemiology - poverty and cardiovascular diseases a double burden in African population. IntechOpen; 2021 [cited 2021 July 2]. Available from: https://www.intechopen.com/predownload/77227
   Google Scholar
• Mensah GA, Sampson UK, Roth GA, et al. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990–2013: a systematic analysis of data from the global burden of disease study 2013. Cardiovasc J Afr. 2015;26(2H3Africa Suppl):S6.
   PubMedGoogle Scholar
• Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PloS One. 2020;15(5):e0233147.
   PubMed Web of Science ®Google Scholar
• Caliskan T, Saylan B. Smoking and comorbidities are associated with COVID-19 severity and mortality in 565 patients treated in Turkey: a retrospective observational study. Rev Assoc Med Bras (1992). 2020;66(12):1679–1684.
   PubMed Web of Science ®Google Scholar
• Salah HM, Sharma T, Mehta J. Smoking doubles the mortality risk in COVID-19: a meta-analysis of recent reports and potential mechanisms. Cureus. 2020;12(10):e10837.
   PubMed Web of Science ®Google Scholar
• Ministry of Health and Social Services Namibia. National multisectoral strategic plan for prevention and control of Non-Communicable Diseases (NCDs) in Namibia 2017/18–2021/22. 2017 [cited 2021 June 30]. Available from: https://www.iccp-portal.org/system/files/plans/NAMIBIA%20NATIONAL%20MULTISECTORAL%20STRATEGIC%20PLAN%20FOR%20PREVENTION%20AND%20CONTROL%20OF%20NCDs.pdf
   Google Scholar
• Husain MJ, English LM, Ramanandraibe N. An overview of tobacco control and prevention policy status in Africa. Prev Med. 2016;91S:S16–S22.
   PubMedGoogle Scholar
• Oni T, Berkowitz N, Kubjane M, et al. Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control. Eur Respir J. 2017;50(1):1700004.
   PubMed Web of Science ®Google Scholar
• Godman B, Basu D, Pillay Y, et al. Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future. Front Pharmacol. 2020;11:108.
   PubMed Web of Science ®Google Scholar
• Aungkulanon S, Pitayarangsarit S, Bundhamcharoen K, et al. Smoking prevalence and attributable deaths in Thailand: predicting outcomes of different tobacco control interventions. BMC Public Health. 2019;19(1):984.
   PubMedGoogle Scholar
• Drope J, Schluger N, Cahn Z, et al. 2018. The tobacco atlas. Atlanta: American Cancer Society and Vital Strategies. [cited 2021 June 30]. Available from: https://tobaccoatlas.org/wp-content/uploads/2018/03/TobaccoAtlas_6thEdition_LoRes_Rev0318.pdf
   Google Scholar
• Trofor AC, Papadakis S, Lotrean LM, et al. Knowledge of the health risks of smoking and impact of cigarette warning labels among tobacco users in six European countries: findings from the EUREST-PLUS ITC Europe surveys. Tob Induc Dis. 2018;16:A10.
   PubMed Web of Science ®Google Scholar
• Lindson N, Klemperer E, Hong B, et al. Smoking reduction interventions for smoking cessation. Cochrane Database Syst Rev. 2019;9:Cd013183.
   PubMedGoogle Scholar
• Ministry of Health and Social Services Namibia. Current Namibia medicines register 2015. Namibia: Ministry of Health.
   Google Scholar
• Kamati M, Godman B, Kibuule D. Prevalence of self-medication for acute respiratory infections in young children in Namibia: findings and implications. J Res Pharm Pract. 2019;8(4):220–224.
   PubMed Web of Science ®Google Scholar
• Kibuule D, Nambahu L, Sefah IA, et al. Activities in Namibia to limit the prevalence and mortality from COVID-19 including community pharmacy activities and the implications. Sch Acad J Pharm. 2021;10(5):82–92.
   Google Scholar
• Kalungia AC, Burger J, Godman B, et al. Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia. Expert Rev Anti Infect Ther. 2016;14(12):1215–1223.
   PubMed Web of Science ®Google Scholar
• Kibuule D, Kagoya HR, Godman B. Antibiotic use in acute respiratory infections in under-fives in Uganda: findings and implications. Expert Rev Anti Infect Ther. 2016;14(9):863–872.
   PubMed Web of Science ®Google Scholar
• Abdullah AS, Stillman FA, Yang L, et al. Tobacco use and smoking cessation practices among physicians in developing countries: a literature review (1987–2010). Int J Environ Res Public Health. 2013;11(1):429–455.
   PubMed Web of Science ®Google Scholar
• Steliga MA. Smoking cessation in clinical practice: how to get patients to stop. Semin Thorac Cardiovasc Surg. 2018;30(1):87–91.
   PubMed Web of Science ®Google Scholar
• NEMLIST - Namibia essential medicines list. 6th ed. 2016 Feb, Ministry of Health, Namibia, [cited 2021 July 2]. Available from: http://apps.who.int/medicinedocs/documents/s23017en/s23017en.pdf
   Google Scholar
• Kibuule D, Mubita M, Naikaku E, et al. An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia’s public sector: findings and therapeutic implications. Int J Clin Pract. 2017;71(2). DOI:https://doi.org/10.1111/ijcp.12918
   Google Scholar
• Desalu OO, Adekoya AO, Elegbede AO, et al. Knowledge of and practices related to smoking cessation among physicians in Nigeria. J Bras Pneumol. 2009;35(12):1198–1203.
   PubMed Web of Science ®Google Scholar
• Matouq A, Khader Y, Khader A, et al., Knowledge, attitude, and behaviors of health professionals towards smoking cessation in primary healthcare settings. Transl Behav Med. 2018;8(6):938–943.
   PubMed Web of Science ®Google Scholar
• Eldein HN, Mansour NM, Mohamed SF. Knowledge, attitude and practice of family physicians regarding smoking cessation counseling in family practice centers, Suez Canal University, Egypt. J Family Med Prim Care. 2013;2(2):159–163.
   PubMedGoogle Scholar
• Keto J, Jokelainen J, Timonen M, et al. Physicians discuss the risks of smoking with their patients, but seldom offer practical cessation support. Subst Abuse Treat Prev Policy. 2015;10:43.
   PubMed Web of Science ®Google Scholar
• Soleymani F, Godman B, Yarimanesh P, et al. Prescribing patterns of physicians working in both the direct and indirect treatment sectors in Iran; findings and implications. JPHS. 2019;10:407–413.
   Google Scholar
• Hassali MA, Kamil TK, Md Yusof FA, et al. General practitioners’ knowledge, attitude and prescribing of antibiotics for upper respiratory tract infections in Selangor, Malaysia: findings and implications. Expert Rev Anti Infect Ther. 2015;13(4):511–520.
   PubMed Web of Science ®Google Scholar
• Fadare JO, Oshikoya KA, Ogunleye OO, et al. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications. Hosp Pract. 2018;46(2):77–87.
   PubMedGoogle Scholar
• Al-Jdani S, Mashabi S, Alsaywid B, et al. Smoking cessation counseling: knowledge, attitude and practices of primary healthcare providers at National Guard Primary Healthcare Centers, Western region, Saudi Arabia. J Family Community Med. 2018;25(3):175–182.
   PubMed Web of Science ®Google Scholar
• Rojewski AM, Bailey SR, and Bernstein SL, et al. Considering systemic barriers to treating tobacco use in clinical settings in the United States. Nicotine Tob Res. 2019;21(11):1453-1461.
   PubMed Web of Science ®Google Scholar
• AlTurkstani A, Alkail B, Hegazy A, et al. Knowledge, attitude, and practice among primary health-care physicians toward smoking cessation in Makkah, Saudi Arabia. Int J Med Sci Public Health. 2016;5:1.
   Google Scholar
• Niaz Q, Godman B, Campbell S, et al. Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications. Int J Clin Pharm. 2020;42(4):1227–1236.
   PubMed Web of Science ®Google Scholar
• Nakwatumbah S, Kibuule D, Godman B, et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications. Expert Rev Anti Infect Ther. 2017;15(7):713–721.
   PubMed Web of Science ®Google Scholar
• Sefah I, Ogunleye O, Essah D, et al. Rapid assessment of the potential paucity and price increases for suggested medicines and protection equipment for COVID-19 across developing countries with a particular focus on Africa and the implications. Front Pharmacol. 2021;11:2055.
   Web of Science ®Google Scholar
• Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis. 2020;18:20.
   PubMed Web of Science ®Google Scholar